World trends for H-pylori eradication therapy and gastric cancer prevention strategy by H-pylori test-and-treat

被引：102
|
作者：
Suzuki, Hidekazu [1 ]
Mori, Hideki [2 ]
机构：
[1] Keio Univ, Fellowship Training Ctr, Med Educ Ctr, Sch Med,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan
[2] Natl Hosp Org Tokyo Med Ctr, Dept Gastroenterol, Meguro Ku, 2-5-1 Higashigaoka, Tokyo 1528902, Japan
来源：
JOURNAL OF GASTROENTEROLOGY | 2018年 / 53卷 / 03期
关键词：
H; pylori; Gastric cancer; Clarithromycin; Metronidazole; Fluoroquinolone; PRIMARY ANTIBIOTIC-RESISTANCE; CONTAINING QUADRUPLE THERAPY; CHRONIC ATROPHIC GASTRITIS; TRIPLE THERAPY; RESCUE THERAPY; ANTIMICROBIAL SUSCEPTIBILITY; ENDOSCOPIC RESECTION; RIFABUTIN RESISTANCE; A-MULTICENTER; DUAL THERAPY;
D O I：
10.1007/s00535-017-1407-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Helicobacter pylori-associated gastritis leads to the development of gastric cancer. Kyoto global consensus report on H. pylori gastritis recommended H. pylori eradication therapy to prevent gastric cancer. To manage H. pylori infection, it is important to choose the appropriate regimen considering regional differences in resistance to clarithromycin and metronidazole. Quinolones and rifabutin-containing regimens are useful as third- and fourth-line rescue therapies.
引用
收藏
页码：354 / 361
页数：8
相关论文
共 50 条
  • [1] World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat
    Hidekazu Suzuki
    Hideki Mori
    [J]. Journal of Gastroenterology, 2018, 53 : 354 - 361
  • [2] Risks of H-pylori "Test-and-Treat" strategy in dyspepsia
    Cohrssen, Andreas
    Schiller, Robert
    [J]. AMERICAN FAMILY PHYSICIAN, 2008, 77 (02) : 146 - 146
  • [3] The "test-and-treat'' strategy for H-pylori and dyspepsia is unsafe.
    Sung, JJY
    Lai, MS
    Lao, W
    Li, TH
    Chan, FKL
    Leung, VKS
    Luk, Y
    Kung, NNS
    Ching, JYL
    Wu, JCY
    Lau, JYW
    Chung, SCS
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A321 - A321
  • [4] A quintuple therapy for H-Pylori eradication
    Zullo, Angelo
    Lorenzetti, Roberto
    Hassan, Cesare
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (11): : 2601 - 2601
  • [5] H-pylori eradication and gastric precancerous lesions
    Farinati, E
    Foschia, F
    Di Mario, F
    Cassaro, M
    Rugge, M
    [J]. GASTROENTEROLOGY, 1998, 115 (02) : 512 - 514
  • [6] Patients on long term acid suppression therapy: Outcome of a 'test and treat' H-pylori eradication strategy
    Rubin, GP
    Bramble, M
    [J]. GUT, 1997, 41 : A204 - A204
  • [7] Beneficial effect of a H-pylori 'test and treat' strategy.
    Chiba, N
    van Zanten, SV
    Sinclair, P
    Ferguson, RA
    Escobedo, S
    [J]. GUT, 2000, 47 : A99 - A99
  • [8] Pragmatic eradication of H-pylori
    Price, J
    Hamilton, W
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 1997, 47 (423): : 660 - 660
  • [9] Nitroimidazoles for H-pylori eradication
    Archimandritis, A
    Tzivras, M
    Balatsos, V
    Delis, V
    Skandalis, N
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (11) : 1563 - 1563
  • [10] H-pylori eradication by LAC
    Harris, A
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (05) : 1001 - 1002
12345